AI’s Role in Reducing Healthcare Waste and Cost

By Michael Awood

October 19, 2023

Healthcare expenditure continues to rise, despite advances in medical training and technology. We’ve touched on this before, using an example from the US, where they have experienced these escalating costs. This was largely healthcare expenditure waste. Unfortunately, underperforming public services and poor health outcomes have been coupled with this. This, however, created the shift towards more efficient, cost-effective solutions. One such solution is the use of Artificial Intelligence (AI) in healthcare, and its role in reducing healthcare waste and cost.

AI has the potential to dramatically reduce inefficiencies in the healthcare system, leading to a more streamlined and cost-effective health ecosystem. This integration into healthcare is able to transform the approach to patient safety, hospital administration, drug development, and treatment decisions. AI is paving the way for rapid care management, enabling healthcare professionals to access real-time patient information at the touch of a button. This ability to quickly access and analyse patient data can significantly reduce casualties in emergency situations. The main outcome created is that of value. 

 

 The Economic Implications of AI in Healthcare

A start-up, backed by the University of Toronto, recently created a supercomputer algorithm to evaluate millions of potential Ebola treatments. This breakthrough creates value through cost and time reduction, and more importantly, it saves lives by improving existing treatments. With consumers (patients) increasingly using wearables, AI utilises this data for early detection of disease. This again reduces healthcare costs. In the referenced study it showed that AI significantly reduces healthcare costs compared to conventional methods.

The cost-saving due to AI used in treatment which has been found to be more effective than in diagnosis. AI not only enhances diagnostic accuracy but also minimizes inaccurate examinations, comforting patients.  In terms of time, AI-assisted tools require less time for diagnosis, resulting in cost savings. For instance, in the initial year, the time savings amount to 3.33 hours per day, and by the tenth year, the time saving reaches 15.17 hours per day. 

 

The Future of AI in Healthcare

AI must meet established quality requirements and importantly regulatory bodies must certify it. This will assist in the utilisation within healthcare, leading to full integration into existing systems. It would be important to conduct an economic analysis to compare the costs of AI-based diagnosis and treatment approaches with conventional approaches. These results show that it can significantly reduce healthcare costs compared to conventional methods.

AI possesses the potential to optimise the healthcare industry by reducing costs, improving efficiency, and enhancing patient care. However, to fully realise this potential, it is crucial to integrate AI into healthcare in a way that is economically viable and meets established quality standards.

 

Cover and in-text images taken from the article in the reference URL below

Reference url

Recent Posts

oral GLP-1 medication
    

Market Leadership in Sight as Eli Lilly’s Oral GLP-1 Medication Orforglipron Succeeds in Phase 3

🌟 Ready for a breakthrough in diabetes management?

Eli Lilly’s oral GLP-1 medication, orforglipron, has completed a successful Phase 3 trial, showing remarkable efficacy in lowering A1C levels and promoting substantial weight loss. As the first oral small molecule GLP-1 receptor agonist, it offers a promising alternative to conventional injectable treatments, potentially improving patient adherence and access.

Dive into the details of this exciting development and what it means for the future of diabetes care!

#SyenzaNews #HealthTech #Innovation #Pharmaceuticals

pediatric thyroid cancer risk
    

Environmental Exposures and Pediatric Thyroid Cancer Risk: Key Findings from a California Study

🌟 Are we overlooking environmental risks in pediatric cancer?

Recent research highlights a troubling link between perinatal exposure to PM2.5 and outdoor artificial light and the increased risk of pediatric thyroid cancer. This pivotal study sheds light on how environmental factors play a critical role in childhood health, particularly among vulnerable populations.

Dive into this important discussion on how addressing these environmental exposures may reduce pediatric thyroid cancer and improve health outcomes for future generations.

#SyenzaNews #EnvironmentalHealth #HealthPolicy #Innovation

capivasertib cost-effectiveness
      

Capivasertib Cost-Effectiveness in Advanced Breast Cancer

💡What’s the strategy to bring capivasertib’s price within reach of breast cancer patients?

A recent study evaluates capivasertib, an AKT inhibitor, as a second-line treatment for advanced breast cancer, revealing that its costs significantly outweigh the added health benefits. The analysis indicates that to be cost-effective, a substantial reduction in its price is necessary.

Delve into the economic implications of this treatment and the pressing need for pricing reforms in healthcare.

#SyenzaNews #HealthEconomics #costeffectiveness #oncology

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.